Grace Therapeutics, Inc. (GRCE) KPIs and segments

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31

Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$1.81−0.04 (-2.43%)

Close on Nov 12, 2026Market cap $38.08MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Grace Therapeutics's business

Coming soon

This tab will track the numbers specific to Grace Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?